Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery

Canadian Journal of Ophthalmology

Volumn 40, Issue 6, 2005, Pages 750-753

  Lee, Sao Bing ^a   Oliver, Karine M ^b   Strube, Yi Ning J ^c   Mohan, Subhash K ^d   Slomovic, Allan R ^a,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e Toronto Western Hospital ^*  (Canada)

Author keywords

Anti infective agents; Atypical mycobacterium infections; Bacterial eye infections; Corneal ulcer; Fluoroquinolones; Laser assisted in situ keratomileusis; LASIK

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; DEXAMETHASONE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ACID FAST BACTERIUM; ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; AQUEOUS HUMOR; ARTICLE; ATYPICAL MYCOBACTERIUM; CASE REPORT; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTIOUS COMPLICATION; KERATITIS; KERATOMILEUSIS; LASER SURGERY; POSTOPERATIVE COMPLICATION; RARE DISEASE;

EID: 30344474254     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(05)80094-8     Document Type: Article

References (15)

1. Pache M, Schipper I, Flammer J, Meyer P. Unilateral fungal and mycobacterial keratitis after simultaneous laser in situ keratomileusis. Cornea 2003;22:72-5.
2. Daines BS, Vroman DT, Sandoval HP, Steed LL, Solomon KD. Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis. J Cataract Refract Surg 2003; 29:1014-8.
3. Winthrop KL, Steinberg EB, Holmes G, et al. Epidemic and sporadic cases of nontuberculous mycobacterial keratitis associated with laser in situ keratomileusis. Am J Ophthalmol 2003;135:223-4.
4. Wallace RJ, Jr, Brown BA, Griffith DE. Nosocomial outbreaks/pseudo- outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol 1998;52:453-90.
5. Holmes G, Bond GB, Fader RC, Fulcher SF. A cluster of cases of Mycobacterium szulgai keratitis that occurred after laser-assisted in situ keratomileusis. Clin Infect Dis 2002;34: 1039-46.
6. Ford JG, Huang AJ, Pflugfelder SC, Alfonso EC, Forster RK, Miller D. Nontuberculous mycobacterial keratitis in south Florida. Ophthalmology 1998;105:1652-8.
7. Abshire R, Cockrum P, Crider J, Schlech B. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment. Clin Ther 2004;26:191-6.
8. Gillespie SH, Morrissey I, Everett D. A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model. J Med Microbiol 2001;50: 565-70.
9. Hyon JY, Joo MJ, Hose S, Sinha D, Dick JD, O'Brien TP. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis. Arch Ophthalmol 2004;112:1166-9.
10. Callegan MC, Ramirez R, Kane ST, Cochran DC, Jensen H. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther 2003;20:246-52.
11. Solomon R, Donnenfeld ED, Perry HD, et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 2005;112:466-9.
12. Kovoor TA, Kim AS, McCulley JP, et al. Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy. Eye Contact Lens 2004;30:90-4.
13. Tipperman R. Pharmacologic considerations for cataract surgery. Curr Opin Ophthalmol 2004;15:51-5.
14. Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. Am J Ophthalmol 2004;138: 33-7.
15. Mah FS. Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections. Curr Opin Ophthalmol 2004;15:316-20.